ATOPTIK, a global leader in high-precision optical components, leverages submicron-level machining and full-chain customization to advance medical device innovation. Its λ/10 surface accuracy (@632.8nm) enhances micro-imaging, achieving 140nm resolution for early cancer detection and boosting OCT retinal imaging speed by 3x.

In laser therapy, ATOPTIK’s high-damage-threshold coatings (<0.1% reflectivity, 5J/cm²) improve surgical efficiency, while miniaturized lenses (1-3mm) enable ultra-thin endoscopes with 150° FOV and 98.7% cancer detection accuracy. For POCT, its molded aspheric lenses cut costs by 80% and enhance wearable SpO2 monitoring and DNA sequencing speed (400bp/s).

ATOPTIK’s innovation platform, offering rapid prototyping, ISO 13485 certification, and R&D partnerships, drives the clinical translation of cutting-edge medical optics.